Your prediction
Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | - | - | - | - | - | - |
| Repligen Corp. | -1.220% | -2.633% | -3.857% | -0.080% | -29.386% | -33.159% | -41.972% |
| Opko Health Inc. | 3.090% | 6.598% | 1.978% | -23.769% | -8.274% | -21.161% | -71.371% |
| Amicus Therapeutics Inc. | -2.510% | 0.164% | 0.164% | 103.667% | 1.833% | 20.990% | 58.701% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat